Coloplast As Sp/Adr (CLPBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 124,916 | 90,495 | 92,128 | 60,361 | 90,662 |
| Marketable Securities | N/A | 2,306 | 28,833 | 31,930 | 31,460 |
| Receivables | 714,867 | 687,645 | 631,855 | 679,282 | 659,659 |
| Inventories | 519,678 | 506,079 | 466,408 | 464,665 | 432,146 |
| TOTAL | $1,413,225 | $1,343,444 | $1,274,007 | $1,278,958 | $1,244,529 |
| Non-Current Assets | |||||
| PPE Net | 721,880 | 689,951 | 625,676 | 652,309 | 605,891 |
| Investments And Advances | 9,935 | 9,799 | 7,002 | 7,436 | 6,149 |
| Intangibles | 2,754,862 | 2,824,792 | 2,718,815 | 2,956,387 | 2,951,949 |
| Other Non-Current Assets | 226,308 | 219,032 | 210,343 | 201,495 | 222,937 |
| TOTAL | $3,712,985 | $3,743,574 | $3,561,836 | $3,817,627 | $3,786,926 |
| Total Assets | $5,126,211 | $5,087,018 | $4,835,843 | $5,096,585 | $5,031,455 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 447,212 | 465,587 | 504,578 | 551,999 | 445,159 |
| Other current liabilities | 737,221 | 667,759 | 718,354 | 291,454 | 597,168 |
| TOTAL | $1,437,332 | $1,359,295 | $1,439,179 | $1,069,589 | $1,234,805 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,393,848 | 2,361,367 | 2,246,228 | 2,385,142 | 2,340,481 |
| Other Non-Current Liabilities | 346,842 | 352,757 | 339,680 | 432,880 | 415,844 |
| TOTAL | $2,740,690 | $2,714,124 | $2,585,908 | $2,818,022 | $2,756,325 |
| Total Liabilities | $4,178,021 | $4,073,419 | $4,025,087 | $3,887,611 | $3,991,130 |
| Shareholders' Equity | |||||
| Common Shares | 31,558 | 31,126 | 29,657 | 31,493 | 30,888 |
| Retained earnings | 1,150,830 | 947,025 | 885,722 | 785,279 | 1,062,347 |
| Other shareholders' equity | -234,199 | 35,448 | -104,623 | 392,202 | -52,910 |
| TOTAL | $948,189 | $1,013,599 | $810,757 | $1,208,974 | $1,040,325 |
| Total Liabilities And Equity | $5,126,210 | $5,087,018 | $4,835,844 | $5,096,585 | $5,031,455 |